Denali Therapeutics Inc. - DNLI
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$4.031B
QoQ value delta ($000)
+$1.193B
(+42.06%)
Implied price effect (QoQ)
+33.73%
Shares
Total shares
157,510,220
QoQ shares delta
+9,232,771
(+6.23%)
Total shares held by funds (by quarter)
Market chart (DNLI)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 297 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.